Compare Eli Lilly And Co (LLY) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Suncor Energy Inc. — how do they compare? Eli Lilly And Co trades at $1,177.75 (market cap $1.04T), while Suncor Energy Inc. trades at $72.07 (market cap $82.76B). The key difference: Eli Lilly And Co is far larger — about 12.6× Suncor Energy Inc.'s market cap, and Suncor Energy Inc. pays the higher dividend (2.39%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Suncor Energy Inc. for 57 Days on average.
| LLY | SU | |
|---|---|---|
Market Cap | $1.04T | $82.76B |
Volume | 3,064,878 | 3,832,959 |
Sector | Health | Energy |
52-Week High | $1.28K | $71.87 |
52-Week Low | $799.57 | $38.17 |
Typical Hold Time | 93 Days | 57 Days |
Enterprise Value | $1.09T | $89.29B |
Dividend Yield | 0.59% | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,179.27, down 0.79% on the day, with a bullish technical outlook and strong fundamental momentum. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 expectation. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing its market leadership.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include competitive pressures in the obesity drug market and execution challenges in scaling production. With a consensus price target of $1,350, representing ~14% upside, the stock offers growth potential but requires monitoring of pipeline progress and market dynamics.
Suncor Energy (SU) trades at $72.23, up 6.0% today and near its 52-week high, reflecting strong momentum. The stock shows bullish technical signals with moving averages supporting further upside, while fundamentals indicate solid profitability with a 14.7% net income margin and attractive valuation at a P/E of 13.46. Recent Q2 2026 earnings beat expectations, and the company is boosting shareholder returns through buybacks and a $0.60 dividend.
The outlook remains positive given robust cash flow, debt reduction, and strategic asset sales, but risks include commodity price volatility and operational disruptions. With 74% analyst buy ratings and institutional confidence, SU offers value in the energy sector, though investors should monitor execution under new leadership and macroeconomic pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
